Top Sell
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Arrowhead Pharmaceuticals Inc. | 21 | 1 | 2 | 0 | €17.07 | €54.83 | 221.195% |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.73 | €4.99 | 588.607% |
| Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
| Biogen Inc. | 55 | 2 | 4 | 0 | €169.15 | €276.44 | 63.432% |
| Bluebird Bio Inc. | 7 | 7 | 0 | 1 | €0.51 | €5.47 | 963.403% |
| Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.25 | €4.61 | 1763.813% |
| Cardiff Oncology Inc. | 2 | 3 | 1 | 0 | €2.34 | - | - |
| Cellectar BioSciences Inc. | 4 | 5 | 0 | 1 | €2.00 | €14.75 | 637.640% |
| Coherus Bioscien. | 1 | 2 | 1 | 0 | €0.95 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.50 | €50.00 | 185.714% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 2 | €0.22 | €14.66 | 6565.591% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.05 | €50.00 | 4652.852% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.00 | - | - |
| Evoke Pharma Inc. | 0 | 24 | 0 | 1 | €0.37 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €2.90 | €7.31 | 151.996% |
| Fibrogen Inc. | 0 | 1 | 0 | 0 | €0.35 | - | - |
| Glycomimetics Inc. | 3 | 10 | 0 | 3 | €0.14 | €9.13 | 6278.911% |
| Gritstone Oncology Inc | 7 | 1 | 2 | 0 | €0.17 | €3.64 | 2001.499% |
| Inotiv Inc. | 4 | 1 | 1 | 0 | €1.71 | €9.93 | 480.602% |
| Integra LifeSciences Holdings Corp | 3 | 7 | 0 | 1 | €15.20 | €45.24 | 197.611% |
| Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | €16.39 | €58.89 | 259.312% |
| InVivo Therapeutics Holdings | 0 | 12 | 0 | 0 | €0.31 | - | - |
| Ionis Pharmaceuticals Inc. | 26 | 6 | 1 | 0 | €34.53 | €56.58 | 63.861% |